Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Breast Cancer × neratinib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Ovarian Neoplasms 2 Recurrence 1 Pathologic Complete Response 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 HER2-positive Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1 Disease 1 Central Nervous System Neoplasms 1 Carcinoma, Lobular 1 Breast Cancer With Brain Metastasis 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Fulvestrant 4 Letrozole 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2 palbociclib 2 talazoparib 1 pyrotinib 1 olaparib 1 eribulin 1 elacestrant 1 disitamab vedotin 1 dalpiciclib 1 abemaciclib 1 Vinorelbine 1 Sirolimus 1 Safety 1 Ritonavir 1 Itraconazole 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1 Anastrozole 1 Alpelisib 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡